Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm-Reference-Cited by-同舟云学术

Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm

Published:2021-05-10 Issue:10 Volume:59 Page:e392-e394
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

De Bruyne Sander¹,Steel Eva²,Petrick Marjan²,Denys Barbara³,Vandepoele Karl³,Van Roy Nadine⁴,Degandt Simon¹,Ghys Timothy¹,Louagie Henk¹

Affiliation:

1. Department of Laboratory Medicine , AZ Sint-Lucas , Ghent , Belgium

2. Department of Haematology , AZ Sint-Lucas , Ghent , Belgium

3. Department of Laboratory Medicine , Ghent University Hospital , Ghent , Belgium

4. Department of Biomolecular Medicine , Ghent University Hospital , Ghent , Belgium

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry, medical,Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2020-1884/pdf

Reference10 articles.

1. Grinfeld, J, Nangalia, J, Baxter, EJ, Wedge, DC, Angelopoulos, N, Cantrill, R, et al.. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med 2018;379:1416–30. https://doi.org/10.1056/nejmoa1716614.

2. Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al.. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2017.

3. Lorenzo, M, Grille, S, Stevenazzi, M. Emergence of BCR-ABL1 chronic myeloid leukemia in a JAK2-V617F polycythemia vera. J Hematol 2020;9:23–9. https://doi.org/10.14740/jh591.

4. Martin-Cabrera, P, Haferlach, C, Kern, W, Schnittger, S, Haferlach, T. BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance. Br J Haematol 2017;176:135–9. https://doi.org/10.1111/bjh.13932.

5. Cerquozzi, S, Tefferi, A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 2015;5:e366. https://doi.org/10.1038/bcj.2015.95.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination;Frontiers in Oncology;2024-01-12

2. Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events;Leukemia Research;2023-03